retatrutide side effects long-term Effects: Risks and Warnings GLP-1 Medications for Weight Loss:

Retatrutide is a triple-agonist that targets GLP-1, GIP, and glucagon receptors, while tesamorelin is a growth hormone-releasing hormone analog

Early access to medication 12-24 months before Health Canada approval

Dosing frequency depends on the specific GLP-1 prescribed: Once-daily injections (e } What to Expect After Starting GLP-1 Injections Its common for licensed providers to start patients at a lower dose, which may minimize side effects and build tolerance

Anjalee Khemlani is the senior health reporter at Yahoo Finance, covering all things pharma, insurance, care services, digital health, PBMs, and health policy and politics